How much progress has there been in vaccinating against Hib in the Americas?

April 22, 2008

The bacterium Haemophilus influenzae type b (Hib) causes at least 3 million cases of severe disease each year, and about 400,000 children die annually due to pneumonia or meningitis caused by Hib.

Vaccines against Hib are both safe and highly effective at reducing disease and deaths from Hib infection, and so the World Health Organization recommends the introduction of Hib vaccines worldwide. In a policy paper in this week's PLoS Medicine, M. Carolina Danovaro-Holliday (Pan American Health Organization; PAHO) and colleagues examine the progress of Hib vaccine introduction in the Americas.

They find that by the end of 2006, all countries of the Americas, except Haiti, had included Hib in their immunization schedule. Factors that favored this region-wide Hib vaccine adoption, they say, included strong political will, data supporting a high Hib disease burden and the positive impact of Hib vaccination in early adopters, and the existence of a mechanism called the Revolving Fund for bulk purchase of vaccines. But "efforts are still needed," say the authors, "to improve vaccination coverage and to strengthen invasive bacterial disease surveillance in developing countries."

Citation: Danovaro-Holliday MC, Garcia S, de Quadros C, Tambini G, Andrus JK (2008) Progress in vaccination against Haemophilus influenzae type b in the Americas. PLoS Med 5(4): e87

Source: PLoS

Explore further: Study finds shifting disease burden following universal Hib vaccination

Related Stories

Study finds shifting disease burden following universal Hib vaccination

November 11, 2011
Vaccination against Haemophilus influenzae type b, or Hib, once the most common cause of bacterial meningitis in children, has dramatically reduced the incidence of Hib disease in young children over the past 20 years, according ...

No Hib booster needed by vaccinated infants in Kenya

February 4, 2016
A 15-year study carried out in Kilifi, Kenya and funded by the Wellcome Trust and Gavi, the Vaccine Alliance has shown that there is no need to give a Hib booster to toddlers to extend immunity into later childhood. The study ...

Study explains how early childhood vaccination reduces leukemia risk

May 18, 2015
A team led by UCSF researchers has discovered how a commonly administered vaccine protects against acute lymphoblastic leukemia (ALL), the most common type of childhood cancer.

Study recalculates costs of combination vaccines

April 17, 2014
One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Why your child still needs vaccines, even if you may not know someone with the disease

April 20, 2017
At the turn of the 21st century, the Centers for Disease Control and Prevention published an article about the 10 greatest public health achievements over the past 100 years, from 1900-1999. One of them was vaccination, which ...

Study: No significant rise in seizure risk from common kids' vaccine

February 22, 2012
(HealthDay) -- Children who receive a combination vaccine known as DTaP-IPV-Hib have no significant increased risk of febrile seizure, a convulsion triggered by a fever, during the week after vaccination, researchers in Denmark ...

Recommended for you

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.